ea0063p517 | Calcium and Bone 2 | ECE2019
Sagar Rebecca
, Rogers Emily
, Chau Vincent
, Bald Alexander
, Potts Sarah
, Cooke Heather
, Orme Steve
, Abbas Afroze
Background: Denosumab is a monoclonal antibody against RANK ligand used for the treatment of osteoporosis. Although clinical trials demonstrate that denosumab is highly effective at reducing fragility fractures in postmenopausal osteoporosis, there have been few studies looking at real world outcomes. Our primary aim was to assess the efficacy of denosumab in practice.Methods: We retrospectively formed a database of 257 patients seen in endocrinology out...